Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.19), versus ($0.25) reported last year. Revenue for the quarter came in at $512 thousand, versus $396 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.